1.Potential strategies for prevention of tumor spillage in minimally invasive radical hysterectomy
Vicente BEBIA ; Sonia MONREAL-CLUA ; Assumpció PÉREZ-BENAVENTE ; Silvia FRANCO-CAMPS ; Berta DÍAZ-FEIJOO ; Antonio GIL-MORENO
Journal of Gynecologic Oncology 2020;31(5):e73-
Objective:
The publication of a prospective [1] and several retrospective [2,3] studies describing a worse prognosis in patients affected with early-stage cervical cancer who underwent a minimally invasive radical hysterectomy has raised a high concern in what measures should be undertaken in order to revert these results. Potential strategies [4] to prevent tumor spillage have been previously proposed.
Methods:
In this video, we describe nine strategies that should be addressed in future trials regarding this procedure.
Results:
These strategies are:1. Fallopian tubes should be coagulated prior to start the surgery.2. All sentinel lymph nodes and lymphadenectomy specimens should be obtained without lymph nodes fragmentation.3. All surgical specimens should be extracted within a containment bag.4. Uterine manipulators must never be used.5. Prior to vaginal section, a closed knotted ligature should be placed around the vagina, proximal to the section line, and the remaining vaginal cavity profusely washed.6. Once the vagina is opened, the surgical specimen should be extracted vaginally within a specimen retrieval bag.7. After surgery, the pelvic cavity is profusely washed with physiological serum, and the vagina should be washed with iodopovidone diluted to 10% [5].8. Port-site metastasis prevention measures should be performed.9. Every action made to prevent tumor spillage should be recorded in the surgical report.
Conclusion
As there is a biological rationale in these measures that would prevent tumor spillage and seeding, there is a need of prospectively exploring them within appropriate studies in order to determine their own oncological outcome.
2.Hysteroscopic myomectomy without anesthesia
Nuria Laia RODRÍGUEZ-MIAS ; Montserrat CUBO-ABERT ; Laura GOMILA-VILLALONGA ; Juanjo GÓMEZ-CABEZA ; Jose Luis POZA-BARRASÚS ; Antonio GIL-MORENO
Obstetrics & Gynecology Science 2019;62(3):183-185
OBJECTIVE: Scarce literature about myoma removal without anesthesia has been published. The aim of this paper is to evaluate the feasibility of a new alternative for a hysteroscopic myomectomy in a conventional office setting, without need for anesthesia. METHODS: Step-by-step description of the surgical technique has been provided, based on video images. An office hysteroscopy was performed in a Gynecological Endoscopy Department of a tertiary European hospital. RESULTS: A 49-year-old woman was referred for management of severe hypermenorrhea. Consent and approval were received from the patient and the institutional review board, respectively. The introduction of a Truclear® hysteroscopic polyp morcellator of 5.5 mm with optic of 0 degrees into the uterine cavity did not require any kind of anesthesia or cervical dilatation. The use of saline flow helped distend the cavity and identify a submucosal myoma. Under direct vision, a full myomectomy was performed via mechanical energy with continuous cutting movements, without any complication. After the procedure was completed, the excised material was aspirated through the device into a collecting pouch. A successful complete morcellation of a Type-0 submucosal leiomyoma with a polyp morcellator device was performed in an outpatient setting. Good medical results, good tolerance by the patient besides lower surgical risks due to mechanical instead of electrical energy are shown. CONCLUSION: In conclusion, this video demonstrates that a hysteroscopic myomectomy can be performed successfully in office with lower risk of complications from the procedure and without use of general anesthesia besides good tolerance by the patient.
Anesthesia
;
Anesthesia, General
;
Endoscopy
;
Ethics Committees, Research
;
Female
;
Humans
;
Hysteroscopy
;
Labor Stage, First
;
Leiomyoma
;
Menorrhagia
;
Middle Aged
;
Morcellation
;
Myoma
;
Outpatients
;
Polyps
;
Pregnancy
;
Uterine Myomectomy
3.The extent of aortic lymphadenectomy in locally advanced cervical cancer impacts on survival
Antoni LLUECA ; Javier ESCRIG ; Antonio GIL-MORENO ; Virginia BENITO ; Alicia HERNÁNDEZ ; Berta DÍAZ-FEIJOO ;
Journal of Gynecologic Oncology 2021;32(1):e4-
Objective:
The prognostic impact of surgical paraaortic staging remains unclear in patients with locally advanced cervical cancer (LACC). The objective of our study was to evaluate the results of the surgical technique of preoperative aortic lymphadenectomy in LACC related to tumor burden and disease spread to assess its influence on survival.
Methods:
Data of 1,072 patients with cervical cancer were taken from 11 Spanish hospitals (Spain-Gynecologic Oncology Group [GOG] working group). Complete aortic lymphadenectomy surgery (CALS) was considered when the lymph nodes (LNs) were excised up to the left renal vein. The extent of the disease was performed evaluating the LNs by calculating the geometric means and quantifying the log odds between positive LNs and negative LNs. The Kaplan-Meier method was used to estimate the survival distribution. A Cox proportional hazards model was used to account for the influence of multiple variables.
Results:
A total of 394 patients were included. Pathological analysis revealed positive aortic LNs in 119 patients (30%). LODDS cut-off value of −2 was established as a prognostic indicator. CALS and LODDS <−2 were associated with better disease free survival and overall survival than suboptimal aortic lymphadenectomy surgery and LODDS ≥−2. In a multivariate model analysis, CALS is revealed as an independent prognostic factor in LACC.
Conclusion
When performing preoperative surgical staging in LACC, it is not advisable to take simple samples from the regional nodes. Radical dissection of the aortic and pelvic regions offers a more reliable staging of the LNs and has a favorable influence on survival.
4.Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancer
Martina Aida ANGELES ; Bastien CABARROU ; Antonio GIL-MORENO ; Asunción PÉREZ-BENAVENTE ; Emanuela SPAGNOLO ; Agnieszka RYCHLIK ; Carlos MARTÍNEZ-GÓMEZ ; Frédéric GUYON ; Ignacio ZAPARDIEL ; Denis QUERLEU ; Claire ILLAC ; Federico MIGLIORELLI ; Sarah BÉTRIAN ; Gwénaël FERRON ; Alicia HERNÁNDEZ ; Alejandra MARTINEZ
Journal of Gynecologic Oncology 2021;32(6):e78-
Objective:
We sought to evaluate the impact on survival of tumor burden and surgical complexity in relation to the number of cycles of neoadjuvant chemotherapy (NACT) in patients with advanced ovarian cancer (OC) with minimal (CC-1) or no residual disease (CC-0).
Methods:
This retrospective study included patients with International Federation of Gynaecology and Obstetrics IIIC–IV stage OC who underwent debulking surgery at 4 high-volume institutions between January 2008 and December 2015. We assessed the overall survival (OS) of primary debulking surgery (PDS group), early interval debulking surgery after 3–4 cycles of NACT (early IDS group) and delayed debulking surgery after 6 cycles (DDS group) with CC-0 or CC-1 according to peritoneal cancer index (PCI) and Aletti score.
Results:
Five hundred forty-nine women were included: 175 (31.9%) had PDS, 224 (40.8%) early IDS and 150 (27.3%) DDS. Regardless of Aletti score, median OS after PDS was significantly higher than after early IDS or DDS, but the survival difference was higher in women with an Aletti score <8. Among patients with PCI ≤10, median OS after PDS was significantly higher than after early IDS or DDS. In women with PCI >10, there were no differences between PDS and early IDS, but DDS was associated with decreased OS.
Conclusion
The benefit of complete PDS compared with NACT was maximal in patients with a low complexity score. In patients with low tumor burden, there was a survival benefit of PDS over early IDS or DDS. In women with high tumor load, DDS impaired the oncological outcome.
5.The Value of Transcranial Doppler Sonography in Hyperperfusion Syndrome after Carotid Artery Stenting: A Nationwide Prospective Study
Francisco MONICHE ; Irene ESCUDERO-MARTÍNEZ ; Fernando MANCHA ; Alejandro TOMASELLO ; Marc RIBÓ ; Fernando DELGADO-ACOSTA ; Juán José OCHOA ; Joaquín GIL ; Rosario GIL ; Montserrat GONZÁLEZ-DELGADO ; Eduardo MURIAS ; Alain LUNA ; Alberto GIL ; Sonia MOSTEIRO ; María Dolores FERNÁNDEZ-COUTO ; Luis Fernández de ALARCÓN ; José M. RAMÍREZ-MORENO ; Joaquín ZAMARRO ; Guillermo PARRILLA ; José L. CANIEGO ; Gustavo ZAPATA-WAINBERG ; Andrés GONZÁLEZ-MANDLY ; José A. de las HERAS ; Luis LÓPEZ-MESONERO ; Joaquín ORTEGA ; Juan F. ARENILLAS ; Ernesto GARCÍA ; Pedro P. ALCÁZAR ; Elena ZAPATA-ARRIAZA ; Asier de ALBÓNIGA-CHINDURZA ; Juan Antonio CABEZAS ; Pilar ALGABA ; Aurelio CAYUELA ; Joan MONTANER ; Alejandro González GARCÍA
Journal of Stroke 2020;22(2):254-257